摘要
目的 :研究胃癌淋巴结微转移的意义。方法 :用常规 HE和免疫组化 CK1 9检测 10 0例胃癌淋巴结转移。结果 :10 0例胃癌中 ,76例淋巴结明显转移 ,6例淋巴结微转移 ,18例无转移。在 P2 7Kip1 和 P5 3表达及 5年生存期上胃癌淋巴结微转移组与转移组比较差异均有显著性 (P<0 .0 5 ) ;相反 ,微转移组与无转移组比较差异均无显著性 (P>0 .0 5 )。结论 :胃癌淋巴结微转移对预后因子 P2 7Kip1 和 P5 3蛋白表达和 5年生存期影响不大 ,依据免疫组化检测胃癌淋巴结微转移灶方法敏感可行 ,但对胃癌患者的临床治疗与预后意义不大。
Objective:The study was designed to investigate the significance of micrometastasis in gastric carcinoma.Methods:The metastasis and micrometastasis in lymph node were determined by routine HE and immunohistochemistry assay.Results:Of the 100 patients, there were 76 patients with lymph node metastasis, 6 patients with micrometastasis and 18 patients with no lymph node metastasis. In the expression of P27 Kip1 protein?P53 protein and 5 year survival rate, the group of lymph node metastasis had statistic significance (P<0.05) to on group of lymph node micrometastasis. On the contrary, the group of lymph node micrometastasis had no statistic significance(P>0.05) on the group of lymph node without metastasis.Conclusions:The lymph node metastasis in gastric carcinoma had little influence to the expression of P27 Kip1 protein?P53 protein and 5 year survival rate. The method was sensitive to the assay of micrometastasis in lymph node of gastric carcinoma by immunohistochemistry, but there was little significance in therapy and prognosis.
出处
《南通医学院学报》
2004年第1期39-41,共3页
ACTA Academiae Medicinae Nantong
关键词
胃癌
微转移
预后
Gastric carcinoma
Micrometastasis
Prognosis